Literature DB >> 26310833

YKL-40/CHI3L1 drives inflammation on the road of tumor progression.

Stephania Libreros1, Vijaya Iragavarapu-Charyulu2.   

Abstract

Inflammation plays a vital role at different stages of tumor progression. The development of tumors is affected by inflammatory mediators produced by the tumor and the host. YKL-40/chitinase-3-like-1 protein is often up-regulated in inflammation-associated diseases. With the use of chronic inflammatory disease systems, we describe the role of YKL-40/chitinase-3-like-1 protein in enhancing the inflammatory response and its implications in tumorigenesis. We also discuss how pre-existing inflammation enhances tumor growth and metastasis. In this mini-review, we highlight the effect of YKL-40/chitinase-3-like-1 protein-associated inflammation in promoting tumor progression. © Society for Leukocyte Biology.

Entities:  

Keywords:  angiogenesis; cytokines; inflammatory bowel; pulmonary inflammation

Mesh:

Substances:

Year:  2015        PMID: 26310833      PMCID: PMC6608021          DOI: 10.1189/jlb.3VMR0415-142R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  30 in total

1.  A robust strategy for proteomic identification of biomarkers of invasive phenotype complexed with extracellular heat shock proteins.

Authors:  Steven G Griffiths; Alan Ezrin; Emily Jackson; Lisa Dewey; Alan A Doucette
Journal:  Cell Stress Chaperones       Date:  2019-10-24       Impact factor: 3.667

2.  Chitinase 3-Like-1-Deficient Splenocytes Deteriorated the Pathogenesis of Acute Graft-Versus-Host Disease via Regulating Differentiation of Tfh Cells.

Authors:  Zengyao Li; Hao Lu; Jian Gu; Jing Liu; Qin Zhu; Yunjie Lu; Xuehao Wang
Journal:  Inflammation       Date:  2017-10       Impact factor: 4.092

3.  YKL-40 promotes the migration and invasion of prostate cancer cells by regulating epithelial mesenchymal transition.

Authors:  Hailong Hao; Lei Wang; Huiqing Chen; Liwu Xie; Tao Bai; Hongyu Liu; Dongwen Wang
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

Review 4.  Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers.

Authors:  Irina Larionova; Gulnara Tuguzbaeva; Anastasia Ponomaryova; Marina Stakheyeva; Nadezhda Cherdyntseva; Valentin Pavlov; Evgeniy Choinzonov; Julia Kzhyshkowska
Journal:  Front Oncol       Date:  2020-10-22       Impact factor: 6.244

5.  iTRAQ-based quantitative proteomic analysis and bioinformatics study of proteins in retinoblastoma.

Authors:  Yong Cheng; Qingyu Meng; Lvzhen Huang; Xuan Shi; Jing Hou; Xiaoxin Li; Jianhong Liang
Journal:  Oncol Lett       Date:  2017-10-19       Impact factor: 2.967

6.  Clonally expanded EOMES+ Tr1-like cells in primary and metastatic tumors are associated with disease progression.

Authors:  Raoul J P Bonnal; Grazisa Rossetti; Enrico Lugli; Marco De Simone; Paola Gruarin; Jolanda Brummelman; Lorenzo Drufuca; Marco Passaro; Ramona Bason; Federica Gervasoni; Giulia Della Chiara; Claudia D'Oria; Martina Martinovic; Serena Curti; Valeria Ranzani; Chiara Cordiglieri; Giorgia Alvisi; Emilia Maria Cristina Mazza; Stefania Oliveto; Ylenia Silvestri; Elena Carelli; Saveria Mazzara; Roberto Bosotti; Maria Lucia Sarnicola; Chiara Godano; Valeria Bevilacqua; Mariangela Lorenzo; Salvatore Siena; Emanuela Bonoldi; Andrea Sartore-Bianchi; Alessio Amatu; Giulia Veronesi; Pierluigi Novellis; Marco Alloisio; Alessandro Giani; Nicola Zucchini; Enrico Opocher; Andrea Pisani Ceretti; Nicolò Mariani; Stefano Biffo; Daniele Prati; Alberto Bardelli; Jens Geginat; Antonio Lanzavecchia; Sergio Abrignani; Massimiliano Pagani
Journal:  Nat Immunol       Date:  2021-05-20       Impact factor: 25.606

7.  CHI3L1 regulates PD-L1 and anti-CHI3L1-PD-1 antibody elicits synergistic antitumor responses.

Authors:  Bing Ma; Bedia Akosman; Suchitra Kamle; Chang-Min Lee; Chuan Hua He; Ja Seok Koo; Chun Geun Lee; Jack A Elias
Journal:  J Clin Invest       Date:  2021-11-01       Impact factor: 14.808

8.  The expression levels of CHI3L1 and IL15Rα correlate with TGM2 in duodenum biopsies of patients with celiac disease.

Authors:  Paola Catrogiovanni; Giuseppe Musumeci; Salvatore Giunta; Rosa Imbesi; Michelino Di Rosa
Journal:  Inflamm Res       Date:  2020-06-04       Impact factor: 6.986

9.  A Distinct Macrophage Subset Mediating Tissue Destruction and Neovascularization in Giant Cell Arteritis: Implication of the YKL-40/Interleukin-13 Receptor α2 Axis.

Authors:  Yannick van Sleen; William F Jiemy; Sarah Pringle; Kornelis S M van der Geest; Wayel H Abdulahad; Maria Sandovici; Elisabeth Brouwer; Peter Heeringa; Annemieke M H Boots
Journal:  Arthritis Rheumatol       Date:  2021-11-01       Impact factor: 15.483

10.  Serum IL6 as a Prognostic Biomarker and IL6R as a Therapeutic Target in Biliary Tract Cancers.

Authors:  Julia S Johansen; Jesper B Andersen; Dan Høgdall; Colm J O'Rourke; Christian Dehlendorff; Ole F Larsen; Lars H Jensen; Astrid Z Johansen; Hien Dang; Valentina M Factor; Mie Grunnet; Morten Mau-Sørensen; Douglas V N P Oliveira; Dorte Linnemann; Mogens K Boisen; Xin W Wang
Journal:  Clin Cancer Res       Date:  2020-09-15       Impact factor: 13.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.